デフォルト表紙
市場調査レポート
商品コード
1671842

契約臨床調査機関市場:サービスタイプ別、臨床モニタリング、治療領域別、エンドユーザー別、地域別

Contract Clinical Research Organization Market, By Service Type, Clinical Monitoring, By Therapeutic Area, By End User, By Geography


出版日
ページ情報
英文 151 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
契約臨床調査機関市場:サービスタイプ別、臨床モニタリング、治療領域別、エンドユーザー別、地域別
出版日: 2025年02月26日
発行: Coherent Market Insights
ページ情報: 英文 151 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の契約臨床調査機関市場は、2025年には877億1,000万米ドルと推定され、2032年には1,655億6,000万米ドルに達すると予測され、2025年から2032年までのCAGRは9.5%で推移すると予測されています。

レポート対象範囲 レポート詳細
基準年 2024 2025年の市場規模 877億1,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 9.50% 2032年の価値予測 1,655億6,000万米ドル
図.契約臨床調査機関市場シェア(%)、2025年地域別
Contract Clinical Research Organization Market-IMG1

世界の契約臨床調査機関(CRO)市場は、ここ数年着実な成長を遂げています。CROは製薬、バイオテクノロジー、医療機器業界を研究サービスのアウトソーシングという形で支援する企業です。臨床試験デザイン、データ管理、生物統計解析、薬事サービスなどを提供します。創薬・研究開発プロセスの進化は、製薬企業にとって研究の複雑さとコストを増大させ、研究活動のアウトソーシングを余儀なくされています。さらに、医薬品開発サイクルの短縮化により、様々な治療領域における専門知識とインフラを有する外部サービスプロバイダーへの需要が高まっています。これらの要因が契約臨床調査機関市場の成長を大きく後押ししています。

市場力学:

製薬企業の研究開発(R&D)支出の増加と、戦略としてのアウトソーシング採用の増加が、世界の契約臨床調査機関市場を大きく牽引しています。さらに、専門的な臨床試験サービスに対する需要の高まりと先端技術の急速な進化が、この市場に新たな機会を生み出しています。しかし、厳しい規制と承認までの時間の遅れが大きな課題となっています。さらに、知的財産権(IP)やデータセキュリティ関連のリスクも市場の成長をある程度抑制しています。製薬会社は現在、競争優位性を獲得するため、品質、専門知識、先進技術を原動力とするCROの革新的なデリバリーモデルを採用しています。これにより、今後数年間で新たな道が開けると期待されています。

本調査の主な特徴

本レポートでは、世界の契約臨床調査機関市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模(10億米ドル)と年間平均成長率(CAGR%)を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

本書では、世界の契約臨床調査機関(CRO)市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主な企業は、IQVIA、Covance、Syneos Health、PPD(Pharmaceutical Product Development)、ICON plc、Charles River Laboratories、Medpace、Parexel International、WuXi AppTec、PRA Health Sciences、KCR、Celerion、Catalent、BioClinica、Clinipaceなどです。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。

この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。

利害関係者は、世界の契約臨床調査機関市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • ドライバ
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の契約臨床調査機関市場、サービスタイプ別、2020年~2032年

  • 臨床試験サービス
  • 臨床モニタリング
  • 初期開発サービス
  • ラボサービス
  • 規制関連業務サービス

第5章 世界の契約臨床調査機関市場、治療領域別、2020年~2032年

  • 腫瘍学
  • 心血管疾患
  • 感染症
  • 神経学
  • その他の治療領域

第6章 世界の契約臨床調査機関市場、エンドユーザー別、2020年~2032年

  • 製薬会社
  • バイオテクノロジー企業
  • 医療機器企業
  • 調査・学術機関

第7章 世界の契約臨床調査機関市場、地域別、2020年~2032年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第8章 競合情勢

  • IQVIA
  • Covance
  • Syneos Health
  • PPD(Pharmaceutical Product Development)
  • ICON plc
  • Charles River Laboratories
  • Medpace
  • Parexel International
  • WuXi AppTec
  • PRA Health Sciences
  • KCR
  • Celerion
  • Catalent
  • BioClinica
  • Clinipace

第9章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第10章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7680

Global Contract Clinical Research Organization Market is estimated to be valued at US$ 87.71 Bn in 2025 and is expected to reach US$ 165.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: US$ 87.71 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.50% 2032 Value Projection: US$ 165.56 Bn
Figure. Contract Clinical Research Organization Market Share (%), By Region 2025
Contract Clinical Research Organization Market - IMG1

The global contract clinical research organization market has been witnessing steady growth over the past few years. CROs are companies that support the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. They provide clinical trial design, data management, biostatistical analysis, regulatory affairs services, and other services. The evolution of drug discovery and development processes has increased research complexities and costs for pharmaceutical companies, compelling them to outsource their research activities. Moreover, abbreviated drug development cycles have increased the demand for external service providers having expertise and infrastructure across varied therapeutic areas. These factors have boosted the contract clinical research organization market growth significantly.

Market Dynamics:

Rising research and development (R&D) expenditure of pharmaceutical companies along with higher adoption of outsourcing as a strategy is significantly driving the global contract clinical research organization market. Moreover, increasing demand for specialized clinical trial services and rapid evolution of advanced technologies are creating new opportunities in this market. However, stringent regulations and slower approval timelines pose major challenges. Additionally, the intellectual property (IP) rights and data security related risks restrain market growth to some extent. Pharmaceutical companies are now adopting innovative delivery models from CROs driven by quality, expertise, and advanced technologies to gain competitive advantage. This is expected to open up new avenues over the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global contract clinical research organization market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global contract clinical research organization (CRO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Covance, Syneos Health, PPD (Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, and Clinipace

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global contract clinical research organization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract clinical research organization market

Market Segmentation

  • Service Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical Trial Service
    • Phase III
    • Phase II
    • Phase I
    • Phase IV
    • Clinical Monitoring
    • Site Monitoring
    • Data Monitoring
    • Early phase development Services
    • Chemistry, Manufacturing and Controls Services
    • Preclinical Services
    • Laboratory Services
    • Analytical Testing Services
    • Bioanalytical Testing Services
    • Regulatory Affairs Services
  • Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
    • Oncology
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurology
    • Other Therapeutic Areas
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Medical Device Companies
    • Research & Academic Institutions
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • IQVIA
    • Covance
    • Syneos Health
    • PPD (Pharmaceutical Product Development)
    • ICON plc
    • Charles River Laboratories
    • Medpace
    • Parexel International
    • WuXi AppTec
    • PRA Health Sciences
    • KCR
    • Celerion
    • Catalent
    • BioClinica
    • Clinipace

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contract Clinical Research Organization Market, By Service Type
    • Global Contract Clinical Research Organization Market, By Therapeutic Area
    • Global Contract Clinical Research Organization Market, By End User
    • Global Contract Clinical Research Organization Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contract Clinical Research Organization Market, By Service Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Trial Service
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Phase III
    • Phase II
    • Phase I
    • Phase IV
  • Clinical Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Site Monitoring
    • Data Monitoring
  • Early phase development Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Chemistry, Manufacturing and Controls Services
    • Preclinical Services
  • Laboratory Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Analytical Testing Services
    • Bioanalytical Testing Services
  • Regulatory Affairs Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contract Clinical Research Organization Market, By Therapeutic Area, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contract Clinical Research Organization Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Device Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research & Academic Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Clinical Research Organization Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • IQVIA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covance
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Syneos Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PPD (Pharmaceutical Product Development)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ICON plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medpace
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Parexel International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WuXi AppTec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PRA Health Sciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KCR
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celerion
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Catalent
  • BioClinica
  • Clinipace

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us